Gynaecologic oncologist at Clínica Universidad de Navarra. Advanced surgery, research & education in gyn cancer. ENYGO NatRep Spain & Online Education co-chair.
A privilege to speak in Coimbra 🇵🇹 about surgery for recurrent cervical cancer.
Almost 80 years after Brunschwig, pelvic exenteration remains a door of hope for very selected patients.
Wise indication 🎯. Specialised centres 🏥. Teamwork 🤝!!!
Muito obrigado!!!
7 editions, 50+ gynaecologists trained, and one shared goal: improving care for our patients. Proud to see how Dr Luis Chiva’s dream of building a surgical anatomy school at @ClinicaNavarra has become a reality. Onwards to 10 years!
Desde Navarra hasta Kinshasa: el Dr. @Quique_ChC comparte en @NoticiasNavarra un nuevo hito del #ProyectoElikia, con la operación de 10 pacientes con cáncer de cuello uterino en el Hospital Monkole.
https://t.co/rl1X1JHNKk
Très satisfaits du voyage à Monkole de l’équipe médicale de Luis Chiva, Enrique Chacón et Ignacio Chiva qui ont réalisé de nombreuses chirurgies du cancer. Le dépistage précoce du projet Elikia sauve de plus en plus de vies. Merci a tous les sanitaires, partenaires et donateurs.
Vuelvo de Kinshasa con el corazón lleno!!! 10 años después de nacer #ELIKIA, hemos podido diagnosticar y operar a tiempo a mujeres con cáncer de cérvix en Monkole. Un pequeño paso que puede cambiar muchas vidas!!!
🗳️ Ya está abierto el periodo de votación de la Sección de Ginecología Oncológica de la SEGO.
Un honor formar parte de la candidatura liderada por Berta Díaz-Feijoo: liderazgo femenino, nueva generación de ginecólogos oncólogos y un plan estratégico para seguir creciendo!
Back from an inspiring @ESGO_society Congress in Copenhagen 🇩🇰.
We presented our SUROVA predicting score for postoperative complications after PDS, identifying patients with very low vs high risk!
Honoured to join the @ENYGO_official Executive Group. Exciting years ahead!
Back from Medellín 🇨🇴 after the 4th Update Meeting on Women’s Cancer.
Spoke on the clinical insights from our @SENECAStudy + future surgical challenges. Great panel on real-world data with Alexander Melamed & Alejandro Rauh-Hain.
Many thanks @RParejaGineOnco for the invitation!
Next up for 2026 ENYGO Executive Group elections:
Sara Nasser from Italy and Enrique Chacon from Spain. 🇮🇹🇪🇸
Full profiles on the ENYGO website. Read their visions.
More candidates tomorrow. Your vote shapes our future.
This week I had the privilege of defending my PhD thesis 🎓
We tackled the “grey zone” adnexal masses (IOTA Simple Rules inconclusive) and compared 2nd-line triage!
Key takeaways:
✅ Expert US >🧲 MRI >🧪 ROMA
Huge thanks to @ClinicaNavarra for making this possible!!!
@IJGConline @lchiv4 @ClinicaNavarra We’re working on a predictive score for postoperative complications – stay tuned!!!
Meanwhile, huge thanks to Prof. @lchiv4 for his relentless work bringing real-world data on cytoreductive surgery to our field. A true living legend. 🙌 #SUROVAstudy@IJGConline
@IJGConline @lchiv4 @ClinicaNavarra In practice, most patients will still go to IDS. The challenge is to identify the small group who benefit from PDS R0 without complications!!!
Two questions:
1️⃣ Can we really achieve R0?
2️⃣ Can we do it without any complication?
@IJGConline @lchiv4 @ClinicaNavarra But #SUROVAstudy is strongly hypothesis-generating: the longest survivors were those with PDS + R0 + NO postop complications! The key is not PDS vs IDS in theory, but doing the right surgery safely in the right patient!